Atlas Trials

Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)

Clinical trial NCT07317609 · RECRUITING

Trial details

NCT number
NCT07317609
Sponsor
Shanghai Zhongshan Hospital
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma (ESCC)
Start date
2025-07-15
Primary completion
2027-09-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.